TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/5/21 21:05 | 10/4/21 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Melian Agustin | MA | O | Chief Me | S | -447 | 23.91 | 0 | -19 | -4 | 454 | D | ||||||||||||||
9/29/21 16:15 | 9/28/21 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Melian Agustin | MA | O | Chief Me | S | -90 | 24.12 | 0 | -4 | -1 | 472 | D | ||||||||||||||
9/20/21 16:05 | 4/5/21 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Melian Agustin | MA | O | Chief Me | S.m | -897 | 22.11 | 0 | -41 | -8 | 476 | D | ||||||||||||||
3/24/21 16:53 | 3/22/21 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Melian Agustin | MA | O | Chief Me | S | -97 | 25.97 | 0 | -4 | -1 | 517 | D | ||||||||||||||
2/4/21 16:35 | 2/2/21 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Melian Agustin | MA | O | Chief Me | S | -2,259 | 41.19 | 0 | -55 | -10 | 520 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |